BOULOGNE-BILLANCOURT, France–(BUSINESS WIRE)–Regulatory News: Cegedim, an innovative technology and services company, today announced the signature of an agreement for the acquisition of the US based Practice Management business of Nightingale Informatix Corporation by its US subsidiary Pulse System, Inc. The acquisition includes the assets of Nightingale’s Medrium, Ridgemark, Secure Connect and Northern Health Products. Jeff Burton, the Pulse Systems President and CEO stated that “We are exc
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment
(MedPage Today) — Electronic medical records also need to be improved, says Mark Graber, MD
The 2015 Nobel Assembly at Karolinska Institutet has awarded this year’s prize for physiology or medicine to three researchers for their contributions in developing novel therapies against malaria and roundworm parasite infection, according to a press release.Youyou Tu, from the China Academy of Traditional Chinese Medicine, was awarded one half of the prize for the discovery of artemisinin, while the other was jointly awarded to William C. Campbell, PhD, emeritus research fellow at Drew University, New Jersey, and Satoshi Ōmura, PhD, emeritus professor at Kitasato University, Japan, for the discovery (Read more...)
The first patient has been enrolled in Encore Vision’s phase 1/2 trial of EV06, an investigational topical treatment for presbyopia, according to a company press release. EV06 (lipoic acid choline ester) is a compound being developed to reverse age-related changes in the crystalline lens that result in diminished lens elasticity.
A new study compares outcomes between these two drugs in previously untreated patients with neovascular AMD. How do they stack up? BMC Ophthalmology